Literature DB >> 28076879

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

J M Clain1, A M Hummel1, J H Stone2, F C Fervenza1, G S Hoffman3, C G M Kallenberg4, C A Langford3, W J McCune5, P A Merkel6, P A Monach7, P Seo8, R F Spiera9, E W St Clair10, S R Ytterberg1, U Specks1.   

Abstract

Anti-neutrophil cytoplasmic antibodies (ANCA) appear to play an important role in the pathogenesis of ANCA-associated vasculitis (AAV). However, ANCA alone are not sufficient to generate disease, and some evidence suggests that infectious triggers may serve as inciting events for AAV disease activity. Antibodies of the immunoglobulin (Ig)M isotype often serve as markers of recent infection, and IgM ANCA have been identified previously in patients with AAV, although the frequency and clinical relevance of IgM ANCA is not well established. We sought to characterize IgM ANCA more clearly by creating a novel enzyme-linked immunosorbent assay (ELISA) for IgM antibodies to proteinase 3 [IgM proteinase 3 (PR3)-ANCA], which we applied to two large, clinically well-characterized trial cohorts of patients with granulomatosis with polyangiitis and microscopic polyangiitis. In the first cohort, IgM PR3-ANCA occurred with a frequency of 15·0%, and were associated with a higher degree of disease severity and a trend towards a higher rate of alveolar haemorrhage (29·6 versus 15·7%, P = 0·10). Analysis of follow-up samples in this cohort showed that the presence of IgM PR3-ANCA was transient, but could recur. In the second cohort, IgM PR3-ANCA occurred with a frequency of 41·1%, and were also associated with a higher degree of disease severity. A higher rate of alveolar haemorrhage was observed among those with IgM PR3-ANCA (45·3 versus 15·8%; P < 0·001). The association of transient IgM PR3-ANCA with an acute respiratory manifestation of AAV suggests a possible link between an infectious trigger and AAV disease activity.
© 2017 British Society for Immunology.

Entities:  

Keywords:  ANCA-associated vasculitis; alveolar haemorrhage; anti-neutrophil cytoplasmic antibodies; granulomatosis with polyangiitis; immunoglobulin M; microscopic polyangiitis

Mesh:

Substances:

Year:  2017        PMID: 28076879      PMCID: PMC5343341          DOI: 10.1111/cei.12925

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

Authors:  J H Stone; G S Hoffman; P A Merkel; Y I Min; M L Uhlfelder; D B Hellmann; U Specks; N B Allen; J C Davis; R F Spiera; L H Calabrese; F M Wigley; N Maiden; R M Valente; J L Niles; K H Fye; J W McCune; E W St Clair; R A Luqmani
Journal:  Arthritis Rheum       Date:  2001-04

Review 2.  Complexities in the relationship between infection and autoimmunity.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

3.  Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.

Authors:  M Tidman; R Olander; C Svalander; D Danielsson
Journal:  J Intern Med       Date:  1998-08       Impact factor: 8.989

4.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Authors:  R J Falk; S Hogan; T S Carey; J C Jennette
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

5.  Wegener's granulomatosis--increased incidence or increased recognition?

Authors:  D M Carruthers; R A Watts; D P Symmons; D G Scott
Journal:  Br J Rheumatol       Date:  1996-02

6.  Association of ANCA isotype and affinity with disease expression.

Authors:  V L Esnault; N Ronda; D R Jayne; C M Lockwood
Journal:  J Autoimmun       Date:  1993-04       Impact factor: 7.094

7.  A monoclonal antibody (MCPR3-7) interfering with the activity of proteinase 3 by an allosteric mechanism.

Authors:  Lisa C Hinkofer; Susanne A I Seidel; Brice Korkmaz; Francisco Silva; Amber M Hummel; Dieter Braun; Dieter E Jenne; Ulrich Specks
Journal:  J Biol Chem       Date:  2013-07-31       Impact factor: 5.157

8.  Wegener's granulomatosis: role of environmental exposures.

Authors:  G F Duna; M F Cotch; C Galperin; D B Hoffman; G S Hoffman
Journal:  Clin Exp Rheumatol       Date:  1998 Nov-Dec       Impact factor: 4.473

9.  Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.

Authors:  J Sun; D N Fass; J A Hudson; M A Viss; J Wieslander; H A Homburger; U Specks
Journal:  J Immunol Methods       Date:  1998-02-01       Impact factor: 2.303

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  5 in total

1.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

2.  Analysis of Antineutrophil Cytoplasm Antibody from 118 730 Patients in Tertiary Hospitals in Jiangxi Province, China.

Authors:  Liming Tan; Anjun Jiao; Juanjuan Chen; Xiaojing Feng; Liuyue Xu; Siqi He; Fuyan Tan; Yongqing Jiang; Heng Luo; Hua Li; Yang Wu; Yongjian Tian; Tingting Zeng; Jianlin Yu; Liping Cao; Jianfeng Zheng; Hui Xu; Ming Wei; Wen Gan; Weihua Peng; Yanming Liu; Jing Hou; Jiangxia Xu; LiHua Shuai; Wenzhi Huang; Junyun Huang; Yan Lin; Jianrong Liu
Journal:  Med Sci Monit       Date:  2017-09-07

Review 3.  Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.

Authors:  Peter Lamprecht; Anja Kerstein; Sebastian Klapa; Susanne Schinke; Christian M Karsten; Xinhua Yu; Marc Ehlers; Jörg T Epplen; Konstanze Holl-Ulrich; Thorsten Wiech; Kathrin Kalies; Tanja Lange; Martin Laudien; Tamas Laskay; Timo Gemoll; Udo Schumacher; Sebastian Ullrich; Hauke Busch; Saleh Ibrahim; Nicole Fischer; Katrin Hasselbacher; Ralph Pries; Frank Petersen; Gesche Weppner; Rudolf Manz; Jens Y Humrich; Relana Nieberding; Gabriela Riemekasten; Antje Müller
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 4.  Antineutrophil cytoplasmic antibodies (ANCA) - their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis.

Authors:  Justyna FijoŁek; ElŻbieta Wiatr
Journal:  Cent Eur J Immunol       Date:  2020-07-09       Impact factor: 2.085

Review 5.  Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.

Authors:  Jérôme Granel; Brice Korkmaz; Dalila Nouar; Stefanie A I Weiss; Dieter E Jenne; Roxane Lemoine; Cyrille Hoarau
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.